BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35351656)

  • 21. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.
    Moreno M; Pedrosa L; Paré L; Pineda E; Bejarano L; Martínez J; Balasubramaniyan V; Ezhilarasan R; Kallarackal N; Kim SH; Wang J; Audia A; Conroy S; Marin M; Ribalta T; Pujol T; Herreros A; Tortosa A; Mira H; Alonso MM; Gómez-Manzano C; Graus F; Sulman EP; Piao X; Nakano I; Prat A; Bhat KP; de la Iglesia N
    Cell Rep; 2017 Nov; 21(8):2183-2197. PubMed ID: 29166609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal Activity Promotes Glioma Progression by Inducing Proneural-to-Mesenchymal Transition in Glioma Stem Cells.
    Guo X; Qiu W; Wang C; Qi Y; Li B; Wang S; Zhao R; Cheng B; Han X; Du H; Gao Z; Pan Z; Zhao S; Li G; Xue H
    Cancer Res; 2024 Feb; 84(3):372-387. PubMed ID: 37963207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing LncRNA LOXL1-AS1 attenuates mesenchymal characteristics of glioblastoma via NF-κB pathway.
    Wang H; Li L; Yin L
    Biochem Biophys Res Commun; 2018 Jun; 500(2):518-524. PubMed ID: 29678575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma.
    Khan AB; Lee S; Harmanci AS; Patel R; Latha K; Yang Y; Marisetty A; Lee HK; Heimberger AB; Fuller GN; Deneen B; Rao G
    Int J Cancer; 2023 Feb; 152(4):713-724. PubMed ID: 36250346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
    Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
    J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients.
    Hua TNM; Oh J; Kim S; Antonio JM; Vo VTA; Om J; Choi JW; Kim JY; Jung CW; Park MJ; Jeong Y
    Exp Mol Med; 2020 Apr; 52(4):629-642. PubMed ID: 32280134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.
    Minata M; Audia A; Shi J; Lu S; Bernstock J; Pavlyukov MS; Das A; Kim SH; Shin YJ; Lee Y; Koo H; Snigdha K; Waghmare I; Guo X; Mohyeldin A; Gallego-Perez D; Wang J; Chen D; Cheng P; Mukheef F; Contreras M; Reyes JF; Vaillant B; Sulman EP; Cheng SY; Markert JM; Tannous BA; Lu X; Kango-Singh M; Lee LJ; Nam DH; Nakano I; Bhat KP
    Cell Rep; 2019 Feb; 26(7):1893-1905.e7. PubMed ID: 30759398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RBPJ contributes to the malignancy of glioblastoma and induction of proneural-mesenchymal transition via IL-6-STAT3 pathway.
    Zhang G; Tanaka S; Jiapaer S; Sabit H; Tamai S; Kinoshita M; Nakada M
    Cancer Sci; 2020 Nov; 111(11):4166-4176. PubMed ID: 32885530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. USP21 promotes self-renewal and tumorigenicity of mesenchymal glioblastoma stem cells by deubiquitinating and stabilizing FOXD1.
    Zhang Q; Chen Z; Tang Q; Wang Z; Lu J; You Y; Wang H
    Cell Death Dis; 2022 Aug; 13(8):712. PubMed ID: 35974001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
    Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
    Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.
    Bhat KPL; Balasubramaniyan V; Vaillant B; Ezhilarasan R; Hummelink K; Hollingsworth F; Wani K; Heathcock L; James JD; Goodman LD; Conroy S; Long L; Lelic N; Wang S; Gumin J; Raj D; Kodama Y; Raghunathan A; Olar A; Joshi K; Pelloski CE; Heimberger A; Kim SH; Cahill DP; Rao G; Den Dunnen WFA; Boddeke HWGM; Phillips HS; Nakano I; Lang FF; Colman H; Sulman EP; Aldape K
    Cancer Cell; 2013 Sep; 24(3):331-46. PubMed ID: 23993863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
    Zhang LM; Zhou JJ; Luo CL
    Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.
    Rinkenbaugh AL; Cogswell PC; Calamini B; Dunn DE; Persson AI; Weiss WA; Lo DC; Baldwin AS
    Oncotarget; 2016 Oct; 7(43):69173-69187. PubMed ID: 27732951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.
    Bhat KP; Salazar KL; Balasubramaniyan V; Wani K; Heathcock L; Hollingsworth F; James JD; Gumin J; Diefes KL; Kim SH; Turski A; Azodi Y; Yang Y; Doucette T; Colman H; Sulman EP; Lang FF; Rao G; Copray S; Vaillant BD; Aldape KD
    Genes Dev; 2011 Dec; 25(24):2594-609. PubMed ID: 22190458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircKPNB1 mediates a positive feedback loop and promotes the malignant phenotypes of GSCs via TNF-α/NF-κB signaling.
    Jiang Y; Zhao J; Liu Y; Hu J; Gao L; Wang H; Cui D
    Cell Death Dis; 2022 Aug; 13(8):697. PubMed ID: 35945192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells.
    Alarcón S; Toro MLÁ; Villarreal C; Melo R; Fernández R; Ayuso Sacido A; Uribe D; San Martín R; Quezada C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32824670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLK3 promotes the proneural-mesenchymal transition in glioblastoma via transcriptional regulation of C5AR1.
    Yu S; Lv L; Li Y; Ning Q; Liu T; Hu T
    Mol Biol Rep; 2023 Oct; 50(10):8249-8258. PubMed ID: 37568042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.